Legionellosis

ABSTRACT

Community-acquired legionnaires' disease (CALD) has dramatically increased in the Legionella urinary antigen (LUA) era. However, its incidence in each country depends on the specific techniques used for the diagnosis of LD and the mandatory reporting of cases to the local health surveillance system. Moreover, the most recent studies have demonstrated that no clinical data are discriminative enough for the diagnosis of LD. Clinical differences have been observed in sporadic and outbreak-reported cases demonstrating that the earlier the diagnosis of Legionella infection, the more nonspecific the clinical appearance. Fluoroquinolones are the most efficacious drugs against Legionella. The combination of these drugs with azithromycin seems to be promising in the treatment of patients with severe LD. Although outbreaks of LD will continue, the most important objective of the public health authorities should be to reduce their number and size.

KEYWORDS

Legionnaires' disease - community-acquired pneumonia - Legionella spp.

REFERENCES

• 1 Sopena N, Sabrià M, Pedro-Botet M L et al.. Prospective study of community-acquired pneumonia of bacterial etiology in adults.  Eur J Clin Microbiol Infect Dis. 1999;  18 852-858
• 2 Vergis E N, Akbas E, Yu V L. Legionella as a cause of severe pneumonia.  Sem Respir Crit Care Med. 2000;  21 295-304
• 3 Lepine L A, Jernigan D B, Butler J C et al.. A recurrent outbreak of nosocomial legionnaires' disease detected by urinary antigen testing: evidence for long-term colonization of a hospital plumbing system.  Infect Control Hosp Epidemiol. 1998;  19 905-910
• 4 Kool J L, Fiore A E, Kioski C M et al.. More than 10 years of unrecognized nosocomial transmission of legionnaires' disease among transplant patients.  Infect Control Hosp Epidemiol. 1998;  19 898-904
• 5 Sabrià M, Mòdol J M, Garcia-Núñez M et al.. Environmental cultures and hospital-acquired legionnaires' disease: a five-year prospective study in twenty hospitals in Catalonia. Spain.  Infect Control Hosp Epidemiol. 2004;  25 1072-1076
• 6 Marston B J, Plouffle J F, File T M et al.. Incidence of community acquired pneumonia requiring hospitalization.  Arch Intern Med. 1997;  157 1709-1718
• 7 Benin A L, Benson R F, Besser R E. Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis.  Clin Infect Dis. 2002;  35 1039-1046
• 8 Joseph C A. and The European Working Group for Legionella Infection . Legionnaires' disease in Europe 2000-2002.  Epidemiol Infect. 2004;  132 417-424
• 9 Departament de Sanitat i Seguretat Social . Resum de malalties de declaració obligatòria a Catalunya durant l'any 2002.  Bulletí Epidemiològic de Catalunya. 2003;  24 121-132
• 10 Fernández N, Gudiol F, Domínguez J, Ausina V, Sopena N. Legionellosis: clinical manifestations, diagnosis and treatment.  Med Clin (Barc). 2002;  119(Suppl 2) 2-32
• 11 Mulazimoglu L, Yu V L. Can legionnaires' disease be diagnosed by clinical criteria? A critical review.  Chest. 2001;  120 1049-1053
• 12 García-Fulgueiras A, Navarro C, Fenoll D et al.. Legionnaires' disease outbreak in Murcia, Spain.  Emerg Infect Dis. 2003;  9 915-921
• 13 PHLS . Outbreak of legionnaires' disease in Barrow-in-Furness.  Commun Dis Rep CDR Wkly. 2002;  12
• 14 Nakamura H, Yagyu H, Kishi K et al.. A large outbreak of legionnaires' disease due to an inadequate circulating and filtration system for bath water: epidemiologic manifestations.  Intern Med. 2003;  42 806-811
• 15 Jansa J M, Cayla J A, Ferrer D et al.. An outbreak of legionnaires' disease in an inner city district: importance of the first 24 hours in the investigation.  Int J Tuberc Lung Dis. 2002;  6 831-838
• 16 Benin A L, Benson R F, Arnold K E et al.. An outbreak of travel-associated legionnaires' disease and Pontiac fever: the need for enhanced surveillance of travel-associated legionellosis in the United States.  J Infect Dis. 2002;  185 237-243
• 17 Den Boer J W, Yzerman E P, Schellekens J et al.. A large outbreak of legionnaires' disease at a flower show, the Netherlands, 1999.  Emerg Infect Dis. 2002;  8 37-43
• 18 Sax H, Dharan S, Pittet D. Legionnaires' disease in a renal transplant recipient: nosocomial or home grown?.  Transplantation. 2002;  74 890-892
• 19 Pedro-Botet M L, Stout J E, Yu V L. Legionnaires' disease contracted from patient homes: the coming of the third plague?.  Eur J Clin Microbiol Infect Dis. 2002;  21 699-705
• 20 Franzin L, Scolfaro C, Cabodi D, Valera M, Tovo P A. Legionella pneumophila pneumonia in a newborn after water birth: a new mode of transmission.  Clin Infect Dis. 2001;  33 e103-104
• 21 Skogberg K, Nuorti J P, Saxen H et al.. A newborn with domestically acquired legionnaires' disease confirmed by molecular typing.  Clin Infect Dis. 2002;  35 e82-85
• 22 Cianciotto N P. Pathogenicity of Legionella pneumophila .  Int J Med Microbiol. 2001;  29 331-343
• 23 Steinert M, Hentschel U, Hacker J. Legionella pneumophila: an aquatic microbe goes astray.  FEMS Microbiol Rev. 2002;  26 149-162
• 24 Sabria M, Yu V L. Hospital-acquired legionellosis: solutions for a preventable infection.  Lancet Infect Dis. 2002;  2 368-373
• 25 Pedro-Botet M L, Sabria M, Sopena N et al.. Environmental legionellosis and oropharyngeal colonization Legionella in immunosuppressed patients.  Infect Control Hosp Epidemiol. 2002;  23 279-281
• 26 Benito J R, Montejo J M, Cancelo L et al.. Community-acquired pneumonia due to Legionella pneumophila serogroup 1: study of 97 cases.  Enferm Infec Microbiol Clin. 2003;  21 394-400
• 27 Bello L, Canle D, Sousa D et al.. Legionella pneumonia: description of a series of 42 cases (in Spanish). XI Spanish Congress of Infectious Diseases and Clinical Microbiology Society.  Enferm Infec Microbiol Clin. 2004;  22 51 , (P 141)
• 28 Sopena N, Sabriá-Leal M, Pedro-Botet M L et al.. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.  Chest. 1998;  113 1195-1200
• 29 Pascual J M, Redon J, Borras R et al.. Legionella pneumophila pneumonia: clinical characteristics of 52 cases.  Med Clin (Barc). 1987;  89 489-493
• 30 Greig J E, Carnie J A, Grahan F T et al.. An outbreak of legionnaires' disease at the Melbourne Aquarium, April 2000: investigation and case-control studies.  Med J Aust. 2004;  180 566-572
• 31 Fraser D W, Tsai T, Orenstein W et al.. Legionnaires' disease: description of an epidemic of pneumonia.  N Engl J Med. 1977;  297 1189-1197
• 32 Kirby B D, Snyder K M, Meyer R D, Finegold S M. Legionnaires' disease: report of sixty-five nosocomially acquired cases and review of the literature.  Medicine (Baltimore). 1980;  59 188-205
• 33 Pedro-Botet M L, Sabriá-Leal M, Haro M et al.. Nosocomial and community-acquired Legionella pneumonia clinical comparative analysis.  Eur Respir J. 1995;  8 1929-1933
• 34 Yu V L, Kroboth F J, Shonnard J, Brown A, McDearman S, Magnussen M. Legionnaires' disease: new clinical perspective from a prospective pneumonia study.  Am J Med. 1982;  73 357-361
• 35 Tan M J, Tan J S, Hamor R H et al.. The radiologic manifestations of legionnaires' disease. The Ohio Community-based pneumonia study group.  Chest. 2000;  117 398-403
• 36 Torres A, Serra-Batlles J, Ferrer A et al.. Severe community-acquired pneumonia: epidemiology and prognostic factors.  Am Rev Respir Dis. 1991;  144 312-318
• 37 Pachon J, Prados M D, Capote F, Cuello J A, Garnacho J, Verano A. Severe community-acquired pneumonia: etiology, prognosis, and treatment.  Am Rev Respir Dis. 1990;  142 369-373
• 38 Falcó V, Fernandez de Sevilla T, Alegre J et al.. Legionella pneumophila: a cause of severe community-acquired pneumonias.  Chest. 1991;  100 1007-1011
• 39 Alvarez-Sanchez B, Alvarez-Lerma F, Jorda R, Serra J, Lopez-Cambra M J, Sandar M D. Prognostic factors and etiology in patients with severe community-acquired pneumonia admitted at the ICU. Spanish multicenter study. Study Group on Severe Community-Acquired Pneumonia in Spain].  Med Clin (Barc). 1998;  111 650-654
• 40 Pedro-Botet M L, Sabrià-Leal M, Sopena N et al.. Role of immunosuppression in the evolution of legionnaires' disease.  Clin Infect Dis. 1998;  26 14-19
• 41 Pedro-Botet M L, Sabrià M, Sopena N et al.. Legionnaires' disease and HIV infection.  Chest. 2003;  124 543-547
• 42 Miller A C. Early clinical differentiation between legionnaires' disease and other sporadic pneumonias.  Ann Intern Med. 1979;  90 526-528
• 43 Granados A, Podzamczer D, Gudiol F et al.. Pneumonia due to L. pneumophila and pneumococcal pneumonia: similarities and differences on presentation.  Eur Respir J. 1989;  2 130-134
• 44 Helms C M, Viner J R, Sturu R H et al.. Comparative features of pneumococcal, Mycoplasma and Legionella pneumonia.  Ann Intern Med. 1979;  90 543-547
• 45 Olaechea P M, Quintana M M, Gallardo M S et al.. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission.  Intensive Care Med. 1996;  22 1294-1300
• 46 Cunha B A. Clinical features of legionnaires' disease.  Semin Respir Infect. 1998;  13 116-127
• 47 Gupta S K, Imperiale T F, Sarosi G A. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia.  Chest. 2001;  120 1064-1071
• 48 Alvarez J, Oyaga N, Escofet N, Codony F, Orcau A, Oliva J M. Leginelosis comunitaria en las comarcas de Barcelona entre 1992 y 1999: características epidemiológicas y métodos diagnósticos.  Med Clin (Barc). 2001;  117 495-496
• 49 Sopena N, Force L, Pedro-Botet M L et al.. Comparative study of Legionella pneumophila according to sporadic and outbreak presentation. 15th European Congress of Clinical Microbiology and Infectious Diseases.  Copenhagen. 2005;  85
• 50 Muder R, Stout J E, Yu V L, Nosocomial M D. Legionella micdadei infection in transplant patients: fortune favors the prepared mind.  Am J Med. 2000;  108 346-348
• 51 Ta A C, Stout J, Yu V. Comparison of culture methods for monitoring Legionella species in hospital potable water systems and recommendations for standardization of such methods.  J Clin Microbiol. 1995;  33 2118-2123
• 52 Plouffe J F, File T M, Breiman R F et al.. Reevaluation of the definition of legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.  Clin Infect Dis. 1995;  20 1286-1291
• 53 Sopena N, Sabria M, Pedro-Botet M L et al.. Factors related to persistence of Legionella urinary antigen excretion in patients with legionnaires' disease.  Eur J Clin Microbiol Infect Dis. 2002;  21 845-848
• 54 Yu V L, Plouffe J F, Pastoris M C et al.. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey.  J Infect Dis. 2002;  186 127-128
• 55 Dominguez J, Gali N, Matas L et al.. Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine simples.  Eur J Clin Microbiol Infect Dis. 1999;  18 896-898
• 56 Murdoch D R, Walford E J, Jennings L C et al.. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia.  Clin Infect Dis. 1996;  23 475-480
• 57 Rantakokko-Jalaba K, Jalaba J. Development of conventional and real-time PCR assays for detection of Legionella DNA in respiratory specimens.  J Clin Microbiol. 2001;  39 2904-2910
• 58 Edelstein P H. Antimicrobial chemotherapy for legionnaires' disease: a review.  Clin Infect Dis. 1995;  21 S265-S276
• 59 Meyer R D, Finegold S M. Legionnaires' disease.  Annu Rev Med. 1980;  31 219-232
• 60 Hays J H, Hinthorn D R, Chonko A et al.. Failure of oral erythromycin therapy for legionnaires' disease in a renal transplant recipient.  South Med J. 1981;  74 1422-1423
• 61 Mercatello A, Frappaz D, Robert D et al.. Failure of erythromycin/rifampicin treatment of Legionella pneumonia.  J Infect. 1985;  10 282-283
• 62 Rudin J E, Evans T L, Wing E J. Failure of erythromycin in treatment of Legionella micdadei pneumonia.  Am J Med. 1984;  76 318-320
• 63 Stout J E, Arnold B, Yu V L. Comparative study of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by microdilution and intracellular susceptibility testing in HL-60 cells.  J Antimicrob Chemother. 1997;  41 289-291
• 64 Stout J, Arnold B, Yu V L. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.  J Antimicrob Chemother. 1998;  41 289-291
• 65 Dubois J, St-Pierre C. In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species.  Clin Microbiol Infect. 1999;  5 205-212
• 66 Edelstein P H, Edelstein M AC. In vitro activity of the ketolide HMR 3647 (TU6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.  Antimicrob Agents Chemother. 1999;  43 90-95
• 67 Edelstein P H, Edelstein M AC. In vitro activity of azithromycin against clinical isolates of Legionella species.  Antimicrob Agents Chemother. 1991;  35 180-181
• 68 Fitzgeorge R B, Lever S, Baskerville A. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne legionnaires' disease.  J Antimicrob Chemother. 1993;  31(Suppl E) 171-176
• 69 Stamler D A, Edelstein M AC, Edelstein P H. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.  Antimicrob Agents Chemother. 1994;  38 217-222
• 70 Plouffe J F, Breiman R F, Fields B S et al.. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.  Clin Infect Dis. 2003;  37 1475-1480
• 71 Edelstein P H, Edelstein M AC, Lehr K H et al.. In vitro activity of levofloxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.  J Antimicrob Chemother. 1996;  37 117-126
• 72 Saito A, Sawatari K, Fukuda Y et al.. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.  Antimicrob Agents Chemother. 1985;  28 15-20
• 73 Stout J E, Arnold B, Yu V L. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.  Diagn Microbiol Infect Dis. 1998;  30 37-43
• 74 Sabrià M, Yu V L. Legionella species (legionnaires' disease). In: Yu VL, Weber R, Raoult D Antimicrobial Therapy and Vaccines. 2nd ed. New York; Apple Trees Productions, LLC 2002: 395-417
• 75 Wynkel A, Toupance O, Melin J P et al.. Traitement des légionelloses par ofloxacine chez le transplant renal: abscence d'interférence avec la ciclosporine A.  Presse Med. 1991;  20 291-293
• 76 Mateu L, Pedro-Botet M L, Sopena N et al.. Fluoroquinolones in the treatment of community and hospital-acquired Legionella pneumonia (P 885). 15th European Congress of Clinical Microbiology and Infectious Diseases.  Copenhagen. 2005;  268
• 77 Salord J M, Matsiota-Bernard P, Staikowsky F et al.. Unsuccessful treatment of Legionella pneumophila infection with a fluoroquinolone.  Clin Infect Dis. 1993;  17 518-519
• 78 Unertl K E, Lenhart F P, Forst H et al.. Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin.  Am J Med. 1989;  87(Suppl 5A) 128S-131S
• 79 Kurz R W, Graninger W, Egger T P et al.. Failure of treatment of Legionella pneumophila with ciprofloxacin.  J Antimicrob Chemother. 1988;  22 389-391
• 80 Drusano G, Lebro M T, Cars O et al.. Pharmacokinetics and pharmacodynamics of fluoroquinolones.  Clin Microbiol Infect. 1998;  4(suppl 2) S27-S41
• 81 Baltch A L, Smith R P, Franke M A et al.. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila. .  Antimicrob Agents Chemother. 1998;  42 3153-3156
• 82 Yu V L, Greenberg R N, Zadeikis N et al.. Levofloxacin efficacy in the treatment of community-acquired legionellosis.  Chest. 2004;  125 2135-2139
• 83 Mykietiuk A, Carratalà J, Fernández-Sabé N et al.. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.  Clin Infect Dis. 2005;  40 794-799
• 84 Blazquez Garrido R M, Espinosa Parra F J, Alemany Francés L et al.. Antimicrobial chemotherapy for legionnaires' disease: levofloxacin versus macrolides.  Clin Infect Dis. 2005;  40 800-806
• 85 Sabrià M, Pedro-Botet M L, Gómez J for the Legionniares' Disease Therapy Group et al. Fluoroquinolones versus macrolides in the treatment of legionnaires' disease.  Chest. 2005;  128. 1401-1405
• 86 Trubel H K, Meyer H G, Jahn B, Knuf M, Kamin W, Huth R G. Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child.  Scand J Infect Dis. 2002;  34 219-221
• 87 Stroup J S, Hendrickson S E, Neil M. Legionella pneumonia and HIV infection: a case report.  AIDS Read. 2004;  14 267-271
• 88 Martin S J, Pendland S L, Chen C, Schreckenberger P, Danzinger L H. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella .  Antimicrob Agents Chemother. 1996;  40 1419-1421
• 89 Martin S J, Pendland S L, Chen C, Schreckenberger P, Danzinger L H. In vitro activity of clarithromycin alone and in combination with ciprofloxacin or levofloxacin against Legionella spp.: enhanced effect by the addition of the metabolite 14-hydroxyclarithromycin.  Diagn Microbiol Infect Dis. 1997;  29 167-171
• 90 Marston B J, Lipman H B, Breiman R F. Surveillance for legionnaires' disease: risk factors for morbidity and mortality.  Arch Intern Med. 1994;  154 2417-2422
• 91 Bollin G E, Plouffe J F, Para M F, Prior R B. Difference in virulence of environmental isolates of Legionella pneumophila. .  J Clin Microbiol. 1985;  21 674-677
• 92 Dennis P J, Lee J V. Differences in aerosol survival between pathogenic and nonpathogenic strains of Legionella pneumophila serogroup 1.  J Appl Bacteriol. 1988;  65 135-141
• 93 Summersgill J T, Raff M J, Miller R D. Interaction of virulent and avirulent Legionella pneumophila with human monocytes.  J Leukoc Biol. 1990;  47 31-38
• 94 Heath C H, Grove D I, Looke D FM. Delay in appropriate therapy of Legionella pneumonia associated with increased mortality.  Eur J Clin Microbiol Infect Dis. 1996;  15 286-290
• 95 Gacouin A, Le Tulzo Y, Lavoue S et al.. Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy.  Intensive Care Med. 2002;  28 686-691
• 96 Chow J W, Yu V L. Legionella: a major opportunistic pathogen in transplant recipients.  Semin Respir Infect. 1998;  13 132-139